COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 5 of 63 for:    Lixisenatide

The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects (Px-Lixi)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02640118
Recruitment Status : Completed
First Posted : December 28, 2015
Last Update Posted : June 21, 2019
MCM Vaccines B.V.
Information provided by (Responsible Party):
Filip Krag Knop, University Hospital, Gentofte, Copenhagen

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2016
Actual Study Completion Date : July 2016